Protagenic Therapeutics, Inc. (PTIX)

NASDAQ: PTIX · IEX Real-Time Price · USD

0.765

-0.175 (-18.62%)

At close: Jul 2, 2024, 4:00 PM

0.803

+0.038 (4.99%)

After-hours: Jul 2, 2024, 4:38 PM EDT

Protagenic Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	Current	2023	2022	2021	2020	2019	2018 - 1998
Market Capitalization	3	4	7	23	11	14	Upgrade
Market Cap Growth	3.82%	-36.50%	-70.56%	115.87%	-24.81%	-29.50%	Upgrade
Enterprise Value	1	0	-1	13	12	14	Upgrade
PE Ratio	-	-0.88	-1.94	-5.19	-4.27	-8.26	Upgrade
PB Ratio	1.60	1.20	1.00	2.36	-9.46	-22.81	Upgrade
P/FCF Ratio	-1.51	-1.14	-3.46	-8.39	-8.07	-29.65	Upgrade
P/OCF Ratio	-1.56	-1.19	-3.47	-8.39	-8.07	-29.65	Upgrade
EV/EBITDA Ratio	-0.91	-0.07	0.21	-3.34	-5.03	-8.04	Upgrade
EV/EBIT Ratio	-0.90	-0.07	0.21	-3.34	-5.03	-8.04	Upgrade
EV/FCF Ratio	-1.04	-0.09	0.36	-4.80	-8.59	-28.59	Upgrade
Debt / Equity Ratio	-	-	0.05	0.03	-1.19	-0.44	Upgrade
Debt / EBITDA Ratio	-	-	-0.10	-0.08	-0.60	-0.16	Upgrade
Debt / FCF Ratio	-	-	-0.17	-0.11	-1.02	-0.57	Upgrade
Quick Ratio	5.43	6.19	7.12	12.97	1.02	0.67	Upgrade
Current Ratio	5.53	6.41	7.18	13.83	1.34	0.70	Upgrade
Interest Coverage	-77.60	-45.44	-24.87	-8.10	-9.35	-109.22	Upgrade
Return on Equity (ROE)	-156.40%	-101.80%	-45.50%	-62.10%	291.10%	402.60%	Upgrade
Return on Assets (ROA)	-124.80%	-82.20%	-40.50%	-51.70%	-264.50%	-360.20%	Upgrade
Return on Capital (ROIC)	-259.14%	-123.41%	-48.99%	-40.35%	-1138.81%	587.65%	Upgrade
Earnings Yield	-176.36%	-113.89%	-51.42%	-19.26%	-23.43%	-12.10%	Upgrade
FCF Yield	-150.94%	-87.76%	-28.86%	-11.92%	-12.40%	-3.37%	Upgrade
Buyback Yield / Dilution	-2.72%	-0.62%	-17.17%	-42.57%	-0.76%	-	Upgrade
Total Shareholder Return	-2.72%	-0.62%	-17.17%	-42.57%	-0.76%	-	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).